John F. Wood
Nessuna posizione attualmente
Profilo
John F.
Wood worked as a Director at Juvenile Diabetes Research Foundation Canada, Head of Regulatory Affairs & Alliance Management at Amylin Pharmaceuticals, Head of Regulatory Affairs at Arena Pharmaceuticals, VP of Regulatory Affairs & Quality Assurance at Tocagen, and as a Principal at IDEC Pharmaceuticals Corp., Gensia Pharmaceuticals, Inc., and IQVIA RDS Consulting, Inc. He also served as Vice President of Regulatory Affairs & Quality at Neothetics, Inc. Wood earned an undergraduate degree from the University of California San Diego and an MBA from the University of Phoenix.
Precedenti posizioni note di John F. Wood
| Società | Posizione | Fine |
|---|---|---|
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | - |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Consigliere Generale | - |
| FORTE BIOSCIENCES, INC. | Consigliere Generale | - |
Gensia Pharmaceuticals, Inc.
 Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gensia Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products for cardiovascular diseases. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Robert L. Engler, Paul K. Laikind. | Corporate Officer/Principal | - |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formazione di John F. Wood
| University of California San Diego | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 8 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA. | Health Technology |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Gensia Pharmaceuticals, Inc.
Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gensia Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products for cardiovascular diseases. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Robert L. Engler, Paul K. Laikind. | Health Technology |
IQVIA RDS Consulting, Inc.
 IQVIA RDS Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services IQVIA RDS Consulting, Inc. provides global regulatory, compliance, and validation consulting services. The company offers strategic regulatory consulting in the areas of quality systems development and optimization, FDA enforcement solutions, validation, and bioresearch monitoring. It provides services to the pharmaceutical, biotechnology, and medical device industries. The company was founded in 2001 and is located in Vernon Hills, IL. | Commercial Services |
Juvenile Diabetes Research Foundation Canada
 Juvenile Diabetes Research Foundation Canada Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation Canada focuses on type 1 diabetes (T1D) research. The company was founded in 1974 and is headquartered in Toronto, Canada. | Commercial Services |
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- John F. Wood
